PUK - Prudential plc
NYSE
->
Financial Services
->
Insurance—Life
London,
United Kingdom
Type: Equity
PUK price evolution
PUK
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $2440 | $1161 | $1035 | $1694 |
| Inventory | ||||
| Total current assets | $2440 | $1161 | $1035 | $1694 |
| Long term investments | ||||
| Property, plant & equipment | $390 | $374 | $396 | $419 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $174687 | $174066 | $165458 | $165942 |
| Current liabilities | ||||
| Accounts payable | ||||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $4286 | $5009 | $3053 | $9486 |
| Long term debt | $4231 | $4175 | $4222 | $4575 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $158516 | $156243 | $148299 | $148982 |
| Shareholders' equity | ||||
| Retained earnings | $11928 | $10810 | ||
| Other shareholder equity | $16171 | $703 | $17159 | $16960 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 17 Mar 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $7170 | $3250 | ||
| Short term investments | $161385 | $147513 | $178944 | |
| Net receivables | $1161 | $1694 | $1799 | $2695 |
| Inventory | ||||
| Total current assets | $1161 | $1694 | $188676 | $63637 |
| Long term investments | $7352 | $10379 | $10426 | $410792 |
| Property, plant & equipment | $374 | $419 | $478 | $893 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $174066 | $165942 | $199102 | $516097 |
| Current liabilities | ||||
| Accounts payable | $4628 | |||
| Deferred revenue | ||||
| Short long term debt | $5590 | $5076 | $6988 | |
| Total current liabilities | $5009 | $9486 | $178976 | $22552 |
| Long term debt | $4175 | $4575 | $6141 | $8080 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $156243 | $148982 | $182014 | $493978 |
| Shareholders' equity | ||||
| Retained earnings | $11928 | $10810 | $10216 | $14667 |
| Other shareholder equity | $703 | $16960 | $1680 | $3644 |
| Total shareholder equity | $17823 | $16960 | $17088 | $20878 |
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5073 | $10660 | $5336 | $4776 |
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $4282 | $8278 | $4003 | $3524 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $212 | $385 | $228 | $260 |
| Interest expense | -$328 | -$263 | -$158 | -$84 |
| Net income | ||||
| Net income | $120 | $1701 | $944 | $894 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 23 Mar 2023 | 17 Mar 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $10660 | $21940 | $26500 | $55973 |
| Cost of revenue | $49837 | |||
| Gross Profit | $21940 | $26500 | $6136 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $4609 | |||
| Total operating expenses | $8278 | $20487 | $23834 | $53686 |
| Operating income | $1453 | $2666 | $2287 | |
| Income from continuing operations | ||||
| EBIT | $1482 | $3018 | $2287 | |
| Income tax expense | $385 | $475 | $804 | $234 |
| Interest expense | -$263 | -$337 | ||
| Net income | ||||
| Net income | $1701 | $998 | -$2042 | $2118 |
| Income (for common shares) | $998 | -$2042 | $2118 | |
| (in millions $) | 30 Jul 2024 | 31 Jan 2024 | 30 Jul 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$270 | -$360 | $58 | -$39 |
| Financing activities | ||||
| Dividends paid | -$390 | -$533 | -$361 | -$474 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$571 | -$1210 | -$879 | -$2520 |
| Effect of exchange rate | -$105 | -$25 | -$40 | -$175 |
| Change in cash and equivalents | $1227 | -$763 | $406 | -$1656 |
| (in millions $) | 31 Jan 2024 | 23 Mar 2023 | 17 Mar 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | $998 | -$2042 | $2118 | |
| Operating activities | ||||
| Depreciation | $409 | |||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $1078 | $278 | $1966 | |
| Investing activities | ||||
| Capital expenditures | -$34 | -$36 | -$59 | |
| Investments | ||||
| Total cash flows from investing | -$360 | -$39 | -$726 | -$1195 |
| Financing activities | ||||
| Dividends paid | -$533 | -$814 | ||
| Sale and purchase of stock | ||||
| Net borrowings | -$144973 | -$174518 | $845 | |
| Total cash flows from financing | -$1210 | -$2520 | $1265 | $212 |
| Effect of exchange rate | -$25 | $70 | ||
| Change in cash and equivalents | -$763 | -$1656 | -$3754.88 | $1053 |
News
Fundamentals
| Market cap | $22.08B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 1.37B |
| Revenue | $25.84B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $3.66B |
| Revenue Q/Q | -139.04% |
| Revenue Y/Y | -655.27% |
| P/E ratio | 6.03 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.85 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $2.66 |
|---|---|
| ROA | 2.15% |
| ROE | N/A |
| Debt/Equity | 8.77 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.57 |
| Quick ratio | N/A |